THOUSAND OAKS, Calif., May 13 /PRNewswire-FirstCall/ -- Amgen (Nasdaq:
AMGN) will present at the Deutsche Bank 34th Annual Healthcare Conference on
Monday, May 18, 2009 at the InterContinental, Boston, Mass., beginning at 9:20
a.m. Eastern Time. Chairman and Chief Executive Officer Kevin Sharer will
present. Live audio of the presentation will be available over the Internet
and can be accessed from Amgen's Web site, www.amgen.com, under Investors.
Information regarding presentation time, webcast availability, and webcast
links are available on Amgen's Investor Relations Events Calendar.
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe and effective
medicines from lab, to manufacturing plant, to patient. Amgen therapeutics
have changed the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid arthritis, and
other serious illnesses. With a deep and broad pipeline of potential new
medicines, Amgen remains committed to advancing science to dramatically
improve people's lives. To learn more about our pioneering science and our
vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks
David Polk, 805-447-4613 (media)
Arvind Sood, 805-447-1060 (investors)